In this PharmTech video feature, we highlight the week’s industry news in an easy-to-consume, fun format. New roundups will ...

New Scripps Research trial will explore the effects of Lilly’s GLP-1 drug on reducing the symptoms of the debilitating ...

As a contributor of about 30 percent to global growth, China's shift toward innovation-driven development is drawing global investors. Last month, AstraZeneca officially opened a new global R&D center ...

AstraZeneca, Eli Lilly and Merck committed $120 million to develop an advanced pharmaceutical manufacturing training center in Central Virginia.

Changes to vaccine recommendations under Health Secretary Robert F. Kennedy Jr. are confusing professionals in the pharmaceutical and insurance industries.

Rachel Reeves is poised to raise taxes faster than any chancellor in 55 years, as City forecasters warn of a repeat of last ...

Federal enforcement of the False Claims Act (FCA) against healthcare and pharmaceutical companies—especially based on alleged Anti-Kickback Statute (AKS) violations—continues to change, with the ...

Metsera, Inc. ("Metsera" or the "Company") today issued the following statement in response to litigation filed against the Company by Pfizer: "Metsera disagrees with the allegations in Pfizer's ...

New Research Compilation Examines Clinical Studies on Tongkat Ali, Horny Goat Weed, Saw Palmetto, and Other Evidence-Based ...

AUSTIN, Texas, Oct. 31, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ASTC) (the “Company” or (“Astrotech”), today announced that it has appointed Scott Bartley as Interim Chief Financial Officer (“CFO”) of the ...